{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:23:53Z","timestamp":1791278633844,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Aichi Medical University Alumni Association"},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-07-Physio-016-01"],"award-info":[{"award-number":["ANR-07-Physio-016-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","award":["ANR-07-Physio-016-01"],"award-info":[{"award-number":["ANR-07-Physio-016-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the European Community of the 7th Framework Program","award":["HEALTH-F2-2007-201590"],"award-info":[{"award-number":["HEALTH-F2-2007-201590"]}]},{"name":"the European Community of the 7th Framework Program","award":["HEALTH-F2-2007-201590"],"award-info":[{"award-number":["HEALTH-F2-2007-201590"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10157-016-1235-2","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T05:37:38Z","timestamp":1454305058000},"page":"117-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Circulating antibodies to \u03b1-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy"],"prefix":"10.1007","volume":"21","author":[{"given":"Yukihiro","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Debiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harutaka","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,1]]},"reference":[{"issue":"1","key":"1235_CR1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.ajkd.2010.01.008","volume":"56","author":"RJ Glassock","year":"2010","unstructured":"Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis. 2010;56(1):157\u201367.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1235_CR2","first-page":"57","volume":"58","author":"T Doi","year":"1984","unstructured":"Doi T, Mayumi M, Kanatsu K, et al. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol. 1984;58(1):57\u201362.","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"1235_CR3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2169\/internalmedicine.41.936","volume":"41","author":"A Kuroki","year":"2002","unstructured":"Kuroki A, Shibata T, Honda H, et al. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med. 2002;41(11):936\u201342.","journal-title":"Intern Med"},{"issue":"6","key":"1235_CR4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00467-009-1439-8","volume":"25","author":"Y Segawa","year":"2010","unstructured":"Segawa Y, Hisano S, Matsushita M, et al. IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediatr Nephrol. 2010;25(6):1091\u20139.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"1235_CR5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0272-6386(12)80997-8","volume":"23","author":"M Haas","year":"1994","unstructured":"Haas M. IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. Am J Kidney Dis. 1994;23(3):358\u201364.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1235_CR6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ki.1997.32","volume":"51","author":"H Imai","year":"1997","unstructured":"Imai H, Hamai K, Komatsuda A, et al. IgG subclasses in patient with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 1997;51(1):270\u20136.","journal-title":"Kidney Int"},{"issue":"4","key":"1235_CR7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/ajkd.2002.31987","volume":"39","author":"K Nagahama","year":"2002","unstructured":"Nagahama K, Matsushita H, Hara M, et al. Bucillamine induces membranous glomerulonephritis. Am J Kidney Dis. 2002;39(4):706\u201312.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1235_CR8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ndt\/gfg616","volume":"19","author":"H Ohtani","year":"2004","unstructured":"Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19(3):574\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"26","key":"1235_CR9","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa012895","volume":"346","author":"H Debiec","year":"2002","unstructured":"Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis from to anti-neutral endopeptidase antibodies. N Engl J Med. 2002;346(26):2053\u201360.","journal-title":"N Engl J Med"},{"issue":"9441","key":"1235_CR10","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(04)17142-0","volume":"364","author":"H Debiec","year":"2004","unstructured":"Debiec H, Nauta J, Coulet F, et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet. 2004;364(9441):1252\u20139.","journal-title":"Lancet"},{"issue":"1","key":"1235_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11\u201321.","journal-title":"N Engl J Med"},{"issue":"3","key":"1235_CR12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2008121259","volume":"21","author":"M Prunotto","year":"2010","unstructured":"Prunotto M, Carnevali ML, Candiano G, et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol. 2010;21(3):507\u201319.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1235_CR13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2249.1999.01080.x","volume":"118","author":"H Wakui","year":"1999","unstructured":"Wakui H, Imai H, Komatsuda A, et al. Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy. Clin Exp Immunol. 1999;118(3):445\u201350.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"1235_CR14","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jprot.2011.05.021","volume":"74","author":"M Bruschi","year":"2011","unstructured":"Bruschi M, Carnevali ML, Murtas C, et al. Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens. J Proteomics. 2011;74(10):2008\u201317.","journal-title":"J Proteomics"},{"issue":"9","key":"1235_CR15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2215\/CJN.02170312","volume":"7","author":"C Murtas","year":"2012","unstructured":"Murtas C, Bruschi M, Candiano G, et al. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol. 2012;7(9):1394\u2013400.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"22","key":"1235_CR16","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","volume":"364","author":"H Debiec","year":"2011","unstructured":"Debiec H, Lefeu F, Kemper MJ, et al. Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med. 2011;364(22):2101\u201310.","journal-title":"N Engl J Med"},{"issue":"24","key":"1235_CR17","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014;371(24):2277\u201387.","journal-title":"N Engl J Med"},{"issue":"3","key":"1235_CR18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1568-9972(02)00028-9","volume":"1","author":"P Migliorini","year":"2002","unstructured":"Migliorini P, Pratesi F, Bongiorni F, et al. The targets of nephritogenic antibodies in systemic autoimmune disorders. Autoimmun Rev. 2002;1(3):168\u201373.","journal-title":"Autoimmun Rev"},{"key":"1235_CR19","first-page":"205","volume-title":"Heptinstall\u2019s pathology of the kidney, edn 6","author":"MM Schwartz","year":"2007","unstructured":"Schwartz MM. Membranous glomerulonephritis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall\u2019s pathology of the kidney, edn 6, vol. 1. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 205\u201351."},{"issue":"7","key":"1235_CR20","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2169\/internalmedicine.46.0129","volume":"46","author":"H Yamada","year":"2007","unstructured":"Yamada H, Miura N, Kitagawa W, et al. Membranous nephropathy and pulmonary alveolar proteinosis. Intern Med. 2007;46(7):1441\u20136.","journal-title":"Intern Med"},{"issue":"7","key":"1235_CR21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMc1011678","volume":"364","author":"H Debiec","year":"2011","unstructured":"Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med. 2011;364(7):689\u201390.","journal-title":"N Engl J Med"},{"issue":"3","key":"1235_CR22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.autrev.2006.10.004","volume":"6","author":"B Terrier","year":"2007","unstructured":"Terrier B, Degand N, Guilpain P, et al. Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun Rev. 2007;6(3):176\u201382.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"1235_CR23","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#","volume":"30","author":"S Moscato","year":"2000","unstructured":"Moscato S, Pratesi F, Sabbatini A, et al. Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. Eur J Immunol. 2000;30(12):3575\u201384.","journal-title":"Eur J Immunol"},{"issue":"5","key":"1235_CR24","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.10252","volume":"46","author":"V Saulot","year":"2002","unstructured":"Saulot V, Vittecoq O, Charlionet R, et al. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. 2002;46(5):1196\u2013201.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1235_CR25","first-page":"695","volume":"33","author":"M Mosca","year":"2006","unstructured":"Mosca M, Chimenti D, Pratesi F, et al. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol. 2006;33(4):695\u20137.","journal-title":"J Rheumatol"},{"issue":"2","key":"1235_CR26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/clin.1996.0021","volume":"78","author":"G Adamus","year":"1996","unstructured":"Adamus G, Aptsiauri N, Guy J, et al. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol. 1996;78(2):120\u20139.","journal-title":"Clin Immunol Immunopathol"},{"key":"1235_CR27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pmic.200700794","volume":"8","author":"A Servettaz","year":"2008","unstructured":"Servettaz A, Guilpain P, Camoin L, et al. Identification of target antigens of antiendothelial cell antibodies in healthy individuals: a proteomic approach. Proteomics. 2008;8:1000\u20138.","journal-title":"Proteomics"},{"issue":"6","key":"1235_CR28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1006\/jaut.1998.0239","volume":"11","author":"G Adamus","year":"1998","unstructured":"Adamus G, Amundson D, Seigel GM, et al. Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. J Autoimmun. 1998;11(6):671\u20137.","journal-title":"J Autoimmun"},{"issue":"6","key":"1235_CR29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0896-8411(95)80027-1","volume":"8","author":"M Walter","year":"1995","unstructured":"Walter M, Berg H, Leidenberger FA, et al. Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis. J Autoimmun. 1995;8(6):931\u201345.","journal-title":"J Autoimmun"},{"issue":"1\u20132","key":"1235_CR30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jneuroim.2005.02.004","volume":"162","author":"A Fujii","year":"2005","unstructured":"Fujii A, Yoneda M, Ito T, et al. Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto\u2019s encephalopathy. J Neuroimmunol. 2005;162(1\u20132):130\u20136.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"1235_CR31","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/PL00000910","volume":"58","author":"V Pancholi","year":"2001","unstructured":"Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci. 2001;58(7):902\u201320.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"1235_CR32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1440-1681.2011.05506.x","volume":"38","author":"P Ronco","year":"2011","unstructured":"Ronco P, Debiec H. Advances in membranous nephropathy: success stories of a long journey. Clin Exp Pharmacol Physiol. 2011;38(7):410\u20136.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1235_CR33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2741\/1503","volume":"10","author":"R Lopez-Alemany","year":"2005","unstructured":"Lopez-Alemany R, Suelves M, Diaz-Ramos A, et al. Alpha-enolase plasminogen receptor in myogenesis. Front Biosci. 2005;10(1):30\u20136.","journal-title":"Front Biosci"},{"issue":"7","key":"1235_CR34","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1742-4658.2011.08025.x","volume":"278","author":"M Capello","year":"2011","unstructured":"Capello M, Ferri-Borgogno S, Cappello P, et al. \u03b1-Enolase: a promising therapeutic and diagnostic tumor target. FEBS J. 2011;278(7):1064\u201374.","journal-title":"FEBS J"},{"issue":"2","key":"1235_CR35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10875-006-9065-8","volume":"27","author":"A Magrys","year":"2007","unstructured":"Magrys A, Anekonda T, Ren G, et al. The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. J Clin Immunol. 2007;27(2):181\u201392.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1235_CR36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Beck LH Jr, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22(6):1137\u201343.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1235_CR37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrneph.2012.35","volume":"8","author":"P Ronco","year":"2012","unstructured":"Ronco P, Debiec H. Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol. 2012;8(4):203\u201313.","journal-title":"Nat Rev Nephrol"},{"key":"1235_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.209","author":"E Hoxha","year":"2012","unstructured":"Hoxha E, Knei\u00dfler U, Stege G, et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012;. doi: 10.1038\/ki.2012.209 .","journal-title":"Kidney Int"},{"key":"1235_CR39","doi-asserted-by":"crossref","unstructured":"Akiyama S, Akiyama M, Imai E, Ozaki T, Matsuo S, Maruyama S. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol. 2014 Nov 21. [Epub ahead of print].","DOI":"10.1007\/s10157-014-1054-2"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1235-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-016-1235-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1235-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1235-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:57:26Z","timestamp":1567558646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-016-1235-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1235-2","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,1]]}}}